National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study - PubMed (original) (raw)
Comparative Study
. 2004 Sep 7;110(10):1251-7.
doi: 10.1161/01.CIR.0000140762.04598.F9. Epub 2004 Aug 23.
Affiliations
- PMID: 15326061
- DOI: 10.1161/01.CIR.0000140762.04598.F9
Comparative Study
National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study
Kelly J Hunt et al. Circulation. 2004.
Abstract
Background: To assess the utility of clinical definitions of the metabolic syndrome (MetS) to identify individuals with increased cardiovascular risk, we examined the relation between the MetS, using both the National Cholesterol Education Program (NCEP) and the World Health Organization definitions, and all-cause and cardiovascular mortality in San Antonio Heart Study participants enrolled between 1984 and 1988.
Methods and results: Among 2815 participants, 25 to 64 years of age at enrollment, 509 met both criteria, 197 met NCEP criteria only, and 199 met WHO criteria only. Over an average of 12.7 years, 229 deaths occurred (117 from cardiovascular disease). Moreover, in the primary prevention population of 2372 participants (ie, those without diabetes or cardiovascular disease at baseline), 132 deaths occurred (50 from cardiovascular disease). In the primary prevention population, the only significant association adjusted for age, gender, and ethnic group was between NCEP-MetS and cardiovascular mortality (hazard ratio [HR], 2.01; 95% CI, 1.13-3.57). In the general population, all-cause mortality HRs were 1.47 (95% CI, 1.13-1.92) for NCEP-MetS and 1.27 (95% CI, 0.97-1.66) for WHO-MetS. Furthermore, for cardiovascular mortality, there was evidence that gender modified the predictive ability of the MetS. For women and men, respectively, HRs for NCEP-MetS were 4.65 (95% CI, 2.35-9.21) and 1.82 (95% CI, 1.14-2.91), whereas HRs for WHO-MetS were 2.83 (95% CI, 1.55-5.17) and 1.15 (95% CI, 0.72-1.86).
Conclusions: In summary, although both definitions were predictive in the general population, the simpler NCEP definition tended to be more predictive in lower-risk subjects.
Similar articles
- Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Malik S, et al. Circulation. 2004 Sep 7;110(10):1245-50. doi: 10.1161/01.CIR.0000140677.20606.0E. Epub 2004 Aug 23. Circulation. 2004. PMID: 15326067 - The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
Wang J, Ruotsalainen S, Moilanen L, Lepistö P, Laakso M, Kuusisto J. Wang J, et al. Eur Heart J. 2007 Apr;28(7):857-64. doi: 10.1093/eurheartj/ehl524. Epub 2007 Feb 15. Eur Heart J. 2007. PMID: 17303589 - Impact of diabetes/metabolic syndrome in patients with established cardiovascular disease.
Stern MP, Williams K, Hunt KJ. Stern MP, et al. Atheroscler Suppl. 2005 May;6(2):3-6. doi: 10.1016/j.atherosclerosissup.2005.02.002. Atheroscler Suppl. 2005. PMID: 15823490 - Epidemiology of the metabolic syndrome, 2002.
Meigs JB. Meigs JB. Am J Manag Care. 2002 Sep;8(11 Suppl):S283-92; quiz S293-6. Am J Manag Care. 2002. PMID: 12240700 Review. - Prognostic interactions between cardiovascular risk factors.
Vishram JK. Vishram JK. Dan Med J. 2014 Jul;61(7):B4892. Dan Med J. 2014. PMID: 25123126 Review.
Cited by
- Do Sex and Gender-Related Differences Account to Different Risk of Developing Heart Failure in Middle-Aged People with Metabolic Syndrome?
Bonapace S, Mantovani A. Bonapace S, et al. Metabolites. 2024 Sep 30;14(10):528. doi: 10.3390/metabo14100528. Metabolites. 2024. PMID: 39452909 Free PMC article. - Cumulative effect of metabolic syndrome on the risk of retinal vein occlusion in young patients: A nationwide population-based study.
Kim Y, Kim CG, Kim JW, Han K, Kim JH. Kim Y, et al. PLoS One. 2024 May 20;19(5):e0303871. doi: 10.1371/journal.pone.0303871. eCollection 2024. PLoS One. 2024. PMID: 38768233 Free PMC article. - Chinese herbal medicine Shenqi compound for early intervention in patients at high cardiovascular risk of type 2 diabetes mellitus: the protocol of a multicenter, randomized, double-blind, placebo-controlled trial.
Leng Y, Zhang Z, Yao N, Fu X, Xie H, Gao H, Xie C. Leng Y, et al. Front Cardiovasc Med. 2024 Jan 8;10:1290240. doi: 10.3389/fcvm.2023.1290240. eCollection 2023. Front Cardiovasc Med. 2024. PMID: 38259322 Free PMC article. - Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022.
Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S, Ohmura H, Shoji T, Yokote K, Yoshida H, Yoshida M, Deguchi J, Dobashi K, Fujiyoshi A, Hamaguchi H, Hara M, Harada-Shiba M, Hirata T, Iida M, Ikeda Y, Ishibashi S, Kanda H, Kihara S, Kitagawa K, Kodama S, Koseki M, Maezawa Y, Masuda D, Miida T, Miyamoto Y, Nishimura R, Node K, Noguchi M, Ohishi M, Saito I, Sawada S, Sone H, Takemoto M, Wakatsuki A, Yanai H. Okamura T, et al. J Atheroscler Thromb. 2024 Jun 1;31(6):641-853. doi: 10.5551/jat.GL2022. Epub 2023 Dec 19. J Atheroscler Thromb. 2024. PMID: 38123343 Free PMC article. No abstract available. - A Preliminary Investigation into the Frequency Dose Effects of High-Intensity Functional Training on Cardiometabolic Health.
Smith LE, Van Guilder GP, Dalleck LC, Lewis NR, Dages AG, Harris NK. Smith LE, et al. J Sports Sci Med. 2023 Dec 1;22(4):688-699. doi: 10.52082/jssm.2023.688. eCollection 2023 Dec. J Sports Sci Med. 2023. PMID: 38045746 Free PMC article.
Publication types
MeSH terms
Grants and funding
- 1K01 DK064867/DK/NIDDK NIH HHS/United States
- R01-HL24799/HL/NHLBI NIH HHS/United States
- R01-HL36820/HL/NHLBI NIH HHS/United States
- T32-HL07446/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous